Literature DB >> 12687652

On tests of equivalence via non-unity relative risk for matched-pair design.

Nian-Sheng Tang1, Man-Lai Tang, Ivan Siu Fung Chan.   

Abstract

Matched-pair design is often used in clinical trials to increase the efficiency of treatment comparison. We consider the problem of equivalence test with a relative risk endpoint in matched-pair studies with binary outcomes, and develop several score and Wald-type statistics for testing a hypothesis of non-unity relative risk. Examples from an assessment of HIV screening test and a cross-over clinical trial of soft contact lenses are used to illustrate the proposed methods. Through simulations we compare the empirical performance of these tests with the test proposed by Lachenbruch and Lynch. We show that a score test based on a reparameterized multinomial model by Tango performs best in the sense that the test satisfactorily controls the type I error rate and its empirical type I error rates are generally much closer to the prespecified nominal significance level than those of the other tests. Copyright 2003 John Wiley & Sons, Ltd.

Mesh:

Year:  2003        PMID: 12687652     DOI: 10.1002/sim.1213

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  22 in total

1.  Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests).

Authors:  Kate Cuschieri; Daan Geraets; Jack Cuzick; Louise Cadman; Catherine Moore; Davy Vanden Broeck; Elisaveta Padalko; Wim Quint; Marc Arbyn
Journal:  J Clin Microbiol       Date:  2016-07-06       Impact factor: 5.948

2.  Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.

Authors:  C E Depuydt; I H Benoy; J F A Beert; A M Criel; J J Bogers; M Arbyn
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

3.  p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population.

Authors:  Roosmarijn Luttmer; Maaike G Dijkstra; Peter J F Snijders; Johannes Berkhof; Folkert J van Kemenade; Lawrence Rozendaal; Theo J M Helmerhorst; René H M Verheijen; W Abraham Ter Harmsel; W Marchien van Baal; Peppino G C M Graziosi; Wim G V Quint; Johan W M Spruijt; Dorenda K E van Dijken; Daniëlle A M Heideman; Chris J L M Meijer
Journal:  Mod Pathol       Date:  2016-05-06       Impact factor: 7.842

4.  Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.

Authors:  A T Hesselink; J Berkhof; M L van der Salm; A P van Splunter; T H Geelen; F J van Kemenade; M G B Bleeker; D A M Heideman
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

5.  Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.

Authors:  F M Carozzi; E Burroni; S Bisanzi; D Puliti; M Confortini; P Giorgi Rossi; C Sani; A Scalisi; F Chini
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

6.  Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework.

Authors:  Lan Xu; Anja Oštrbenk Valenčak; Mario Poljak; Marc Arbyn
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

7.  Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.

Authors:  Chris J L M Meijer; Johannes Berkhof; Philip E Castle; Albertus T Hesselink; Eduardo L Franco; Guglielmo Ronco; Marc Arbyn; F Xavier Bosch; Jack Cuzick; Joakim Dillner; Daniëlle A M Heideman; Peter J F Snijders
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

8.  A Comparison of Testing Parameters and the Implementation of a Group Sequential Design for Equivalence Studies Using Paired-sample Analysis.

Authors:  Yunda Huang; Steven G Self
Journal:  Stat Biopharm Res       Date:  2012-01-01       Impact factor: 1.452

9.  Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.

Authors:  Nian-Sheng Tang; Bin Yu; Man-Lai Tang
Journal:  BMC Med Res Methodol       Date:  2014-12-18       Impact factor: 4.615

10.  Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework.

Authors:  K Cuschieri; D T Geraets; C Moore; W Quint; E Duvall; M Arbyn
Journal:  J Clin Microbiol       Date:  2015-08-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.